Dr. Makarand (Mak) Jawadekar devoted most of his working professional years at Pfizer, Inc. based in Groton-New London Connecticut for 28 consecutive years. During his career span at Pfizer, he was responsible for Drug Delivery Technology Assessment function involving external ‘Drug Delivery’ technologies. He has extensive experience in creating and cultivating external partnerships and alliances for Drug Delivery Technologies. He began his professional career at Pfizer Central Research in early 1982, after having completed his Ph.D. in Pharmaceutics, under the guidance of Prof. Edward Rippie at the University of Minnesota.
During his 28+ years of experience with Pfizer Global R&D specifically includes Solids R&D, Drug Product formulation/ Dosage Form/ Drug Delivery development, Clinical Trials Supply Manufacturing, Scale-up and Technology Transfer & Research Pharmacy functions. He helped create various Pharma R&D Partnerships, JVs, and Collaborations. He was also involved in conducting ‘Due-Diligence’ activities as a subject matter expert on behalf of Pfizer for eventual acquisition of companies or their IP assets. He managed several internal functions/groups within R&D for many years. As a bench Scientist, he got to work on many challenging commercial formulations which became multibillion-dollar products for many years for Pfizer Inc. These R & D formulations & Product development programs included Zoloft, Zithromax, Viagra faster onset, Diflucan Orally Dispersible Tablet. He also worked on many “Life Cycle Management “related projects for extending Life-cycle of Pfizer’s existing products. Dr. Jawadekar has presented at over 150+ professional meetings and has participated in various Panel Discussions/Round Tables around the globe.
He was invited by US President George W. Bush to accompany on his Official US delegation trip to India in 2006. He accompanied Presidents of Pfizer R & D to India on 2 separate occasions (in 2007 & again in 2009), where he helped orchestrate for Pfizer R & D to create Partnerships with Indian Multinational Pharma & Technology companies for R & D Collaborations and also represented at the BIOASIA conferences.
Some other notable Post Pfizer career Highlights:
• Worked with KKR, a Private Equity group in New York, for acquisition of Capsugel division from Pfizer which Pfizer divested later in 2011.
With a focus on Innovation and Investment, the Powerful Group responds to the growing demand for a platform that champions ROI-based collaboration and empowerment to Entrepreneurs.
All rights reserved with the Step2StepUp Inc. & Pakute Marketing Pvt. Ltd. | Privacy Policy